Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-35,300
Closed -$6.75M 5721
2023
Q1
$6.75M Buy
+35,300
New +$6.82M ﹤0.01% 1336

Other funds holding STE

Citigroup's STE Position: Q1 2026 in Review

Citigroup increased its Steris (STE) stake by 23% in Q1 2026, buying an estimated $6.02M and bringing the position to 133,377 shares worth $29.5M. The position accounts for 0.01% of the portfolio, ranked #876.

Citigroup first reported a position in STE in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.3M in Q3 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Citigroup held 133,377 shares of Steris worth $29.5M as of Q1 2026.
  • Citigroup bought 24,594 Steris shares in Q1 2026, an estimated $6.02M.
  • Steris made up 0.01% of Citigroup's portfolio in Q1 2026, its #876 holding.
  • Citigroup first reported a position in Steris in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Steris position peaked at $36.3M in Q3 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.